1. Home
  2. JEF vs ALGN Comparison

JEF vs ALGN Comparison

Compare JEF & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JEF
  • ALGN
  • Stock Information
  • Founded
  • JEF 1968
  • ALGN 1997
  • Country
  • JEF United States
  • ALGN United States
  • Employees
  • JEF N/A
  • ALGN N/A
  • Industry
  • JEF Investment Bankers/Brokers/Service
  • ALGN Industrial Specialties
  • Sector
  • JEF Finance
  • ALGN Health Care
  • Exchange
  • JEF Nasdaq
  • ALGN Nasdaq
  • Market Cap
  • JEF 11.0B
  • ALGN 12.5B
  • IPO Year
  • JEF N/A
  • ALGN N/A
  • Fundamental
  • Price
  • JEF $48.58
  • ALGN $180.94
  • Analyst Decision
  • JEF Buy
  • ALGN Buy
  • Analyst Count
  • JEF 4
  • ALGN 13
  • Target Price
  • JEF $56.67
  • ALGN $241.25
  • AVG Volume (30 Days)
  • JEF 1.3M
  • ALGN 920.3K
  • Earning Date
  • JEF 06-25-2025
  • ALGN 07-23-2025
  • Dividend Yield
  • JEF 3.29%
  • ALGN N/A
  • EPS Growth
  • JEF 144.59
  • ALGN N/A
  • EPS
  • JEF 2.90
  • ALGN 5.50
  • Revenue
  • JEF $6,865,419,000.00
  • ALGN $3,980,843,000.00
  • Revenue This Year
  • JEF N/A
  • ALGN $5.73
  • Revenue Next Year
  • JEF $15.07
  • ALGN $5.58
  • P/E Ratio
  • JEF $17.06
  • ALGN $32.90
  • Revenue Growth
  • JEF 33.18
  • ALGN 1.64
  • 52 Week Low
  • JEF $39.28
  • ALGN $141.74
  • 52 Week High
  • JEF $82.68
  • ALGN $271.59
  • Technical
  • Relative Strength Index (RSI)
  • JEF 45.47
  • ALGN 52.76
  • Support Level
  • JEF $47.28
  • ALGN $168.01
  • Resistance Level
  • JEF $50.09
  • ALGN $183.31
  • Average True Range (ATR)
  • JEF 1.19
  • ALGN 4.83
  • MACD
  • JEF -0.25
  • ALGN -0.58
  • Stochastic Oscillator
  • JEF 16.65
  • ALGN 45.58

About JEF Jefferies Financial Group Inc.

Jefferies Financial Group Inc is a full-service investment banking and capital markets firm. It has two reportable segments; Investment Banking and Capital Markets which is also the majority revenue generating segment, includes securities, commodities, corporate lending, futures and foreign exchange capital markets activities and its investment banking business, which provides underwriting and financial advisory services to clients across different sectors. The Asset Management reportable business segment provides alternative investment management services to investors in the U.S. and overseas and generates investment income from capital invested in and managed by it or its affiliated asset managers. Operates geographically in America, Europe and Middle East, Asia Pasific.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: